EE+ POEM Archive
Migraine prevention: Anti-CGRP monoclonal antibodies and onabotulinumtoxinA have similar rates of cardiovascular harm in older adults
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Migraine Prevention: Anti-CGRP Monoclonal Antibodies and onabotulinumtoxinA Have Similar Rates of Cardiovascular Harm in Older Adults." EE+ POEM Archive, John Wiley & Sons, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377377/all/Migraine_prevention:_Anti_CGRP_monoclonal_antibodies_and_onabotulinumtoxinA_have_similar_rates_of_cardiovascular_harm_in_older_adults.
Migraine prevention: Anti-CGRP monoclonal antibodies and onabotulinumtoxinA have similar rates of cardiovascular harm in older adults. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2026. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377377/all/Migraine_prevention:_Anti_CGRP_monoclonal_antibodies_and_onabotulinumtoxinA_have_similar_rates_of_cardiovascular_harm_in_older_adults. Accessed March 6, 2026.
Migraine prevention: Anti-CGRP monoclonal antibodies and onabotulinumtoxinA have similar rates of cardiovascular harm in older adults. (2026). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377377/all/Migraine_prevention:_Anti_CGRP_monoclonal_antibodies_and_onabotulinumtoxinA_have_similar_rates_of_cardiovascular_harm_in_older_adults
Migraine Prevention: Anti-CGRP Monoclonal Antibodies and onabotulinumtoxinA Have Similar Rates of Cardiovascular Harm in Older Adults [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2026. [cited 2026 March 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377377/all/Migraine_prevention:_Anti_CGRP_monoclonal_antibodies_and_onabotulinumtoxinA_have_similar_rates_of_cardiovascular_harm_in_older_adults.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Migraine prevention: Anti-CGRP monoclonal antibodies and onabotulinumtoxinA have similar rates of cardiovascular harm in older adults
ID - 3377377
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377377/all/Migraine_prevention:_Anti_CGRP_monoclonal_antibodies_and_onabotulinumtoxinA_have_similar_rates_of_cardiovascular_harm_in_older_adults
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
